PortalPublikationenTacrolimus and cyclosporine have differential effects on the...

Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.

Standard

Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation. / Treede, Hendrik; Glanville, Allan R; Klepetko, Walter; Aboyoun, Christina; Vettorazzi, Eik; Lama, Raffael; Bravo, Carlos; Knoop, Christiane; Aubert, John-David; Reichenspurner, Hermann; European, [Unbekannt]; Transplantation, Australian Investigators In Lung.

in: J HEART LUNG TRANSPL, Jahrgang 31, Nr. 8, 8, 2012, S. 797-804.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Treede, H, Glanville, AR, Klepetko, W, Aboyoun, C, Vettorazzi, E, Lama, R, Bravo, C, Knoop, C, Aubert, J-D, Reichenspurner, H, European, U & Transplantation, AIIL 2012, 'Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.', J HEART LUNG TRANSPL, Jg. 31, Nr. 8, 8, S. 797-804. <http://www.ncbi.nlm.nih.gov/pubmed/22554673?dopt=Citation>

APA

Treede, H., Glanville, A. R., Klepetko, W., Aboyoun, C., Vettorazzi, E., Lama, R., Bravo, C., Knoop, C., Aubert, J-D., Reichenspurner, H., European, U., & Transplantation, A. I. I. L. (2012). Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation. J HEART LUNG TRANSPL, 31(8), 797-804. [8]. http://www.ncbi.nlm.nih.gov/pubmed/22554673?dopt=Citation

Vancouver

Treede H, Glanville AR, Klepetko W, Aboyoun C, Vettorazzi E, Lama R et al. Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation. J HEART LUNG TRANSPL. 2012;31(8):797-804. 8.

Bibtex

@article{633f9f7b101a40c59d221217dae41cff,
title = "Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.",
abstract = "Chronic lung allograft dysfunction, which manifests as bronchiolitis obliterans syndrome (BOS), is recognized as the primary cause of morbidity and mortality after lung transplantation. In this study we assessed the efficacy and safety of two de novo immunosuppression protocols to prevent BOS.",
keywords = "Adult, Humans, Male, Female, Middle Aged, Risk Factors, Prospective Studies, Treatment Outcome, Survival Rate, Follow-Up Studies, Incidence, Syndrome, Outcome Assessment (Health Care), *International Cooperation, Cyclosporine/adverse effects/*therapeutic use, Bronchiolitis Obliterans/*epidemiology/mortality/*prevention & control, Graft Rejection/epidemiology, Immunosuppressive Agents/adverse effects/therapeutic use, *Lung Transplantation/mortality, Tacrolimus/adverse effects/*therapeutic use, Adult, Humans, Male, Female, Middle Aged, Risk Factors, Prospective Studies, Treatment Outcome, Survival Rate, Follow-Up Studies, Incidence, Syndrome, Outcome Assessment (Health Care), *International Cooperation, Cyclosporine/adverse effects/*therapeutic use, Bronchiolitis Obliterans/*epidemiology/mortality/*prevention & control, Graft Rejection/epidemiology, Immunosuppressive Agents/adverse effects/therapeutic use, *Lung Transplantation/mortality, Tacrolimus/adverse effects/*therapeutic use",
author = "Hendrik Treede and Glanville, {Allan R} and Walter Klepetko and Christina Aboyoun and Eik Vettorazzi and Raffael Lama and Carlos Bravo and Christiane Knoop and John-David Aubert and Hermann Reichenspurner and [Unbekannt] European and Transplantation, {Australian Investigators In Lung}",
year = "2012",
language = "English",
volume = "31",
pages = "797--804",
journal = "J HEART LUNG TRANSPL",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "8",

}

RIS

TY - JOUR

T1 - Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: results of a prospective, randomized international trial in lung transplantation.

AU - Treede, Hendrik

AU - Glanville, Allan R

AU - Klepetko, Walter

AU - Aboyoun, Christina

AU - Vettorazzi, Eik

AU - Lama, Raffael

AU - Bravo, Carlos

AU - Knoop, Christiane

AU - Aubert, John-David

AU - Reichenspurner, Hermann

AU - European, [Unbekannt]

AU - Transplantation, Australian Investigators In Lung

PY - 2012

Y1 - 2012

N2 - Chronic lung allograft dysfunction, which manifests as bronchiolitis obliterans syndrome (BOS), is recognized as the primary cause of morbidity and mortality after lung transplantation. In this study we assessed the efficacy and safety of two de novo immunosuppression protocols to prevent BOS.

AB - Chronic lung allograft dysfunction, which manifests as bronchiolitis obliterans syndrome (BOS), is recognized as the primary cause of morbidity and mortality after lung transplantation. In this study we assessed the efficacy and safety of two de novo immunosuppression protocols to prevent BOS.

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Prospective Studies

KW - Treatment Outcome

KW - Survival Rate

KW - Follow-Up Studies

KW - Incidence

KW - Syndrome

KW - Outcome Assessment (Health Care)

KW - International Cooperation

KW - Cyclosporine/adverse effects/therapeutic use

KW - Bronchiolitis Obliterans/epidemiology/mortality/prevention & control

KW - Graft Rejection/epidemiology

KW - Immunosuppressive Agents/adverse effects/therapeutic use

KW - Lung Transplantation/mortality

KW - Tacrolimus/adverse effects/therapeutic use

KW - Adult

KW - Humans

KW - Male

KW - Female

KW - Middle Aged

KW - Risk Factors

KW - Prospective Studies

KW - Treatment Outcome

KW - Survival Rate

KW - Follow-Up Studies

KW - Incidence

KW - Syndrome

KW - Outcome Assessment (Health Care)

KW - International Cooperation

KW - Cyclosporine/adverse effects/therapeutic use

KW - Bronchiolitis Obliterans/epidemiology/mortality/prevention & control

KW - Graft Rejection/epidemiology

KW - Immunosuppressive Agents/adverse effects/therapeutic use

KW - Lung Transplantation/mortality

KW - Tacrolimus/adverse effects/therapeutic use

M3 - SCORING: Journal article

VL - 31

SP - 797

EP - 804

JO - J HEART LUNG TRANSPL

JF - J HEART LUNG TRANSPL

SN - 1053-2498

IS - 8

M1 - 8

ER -